“Teladoc is becoming the healthcare information backbone of the United States,” says Ark Invest’s Cathie Wood on why she bought $20 million more of the company’s stock despite its disappointing earnings report. pic.twitter.com/Yxs6DiNksi
— CNBC (@CNBC) April 29, 2022